Global Endoscopic Diagnostic and Therapeutic Device Market Strategic Research Report

Scope of the Report

The global Endoscopic Diagnostic and Therapeutic Device market size is predicted to grow from US$ 7,926 million in 2025 to US$ 11,950 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

Endoscopic diagnostic and therapeutic devices are specialized medical instruments designed to be used with endoscopes for the visualization, diagnosis, and treatment of conditions within the body’s internal cavities or luminal organs. These devices can include biopsy forceps, snares, injection needles, electrosurgical tools, and other accessories that enable minimally invasive procedures, allowing for tissue sampling, polyp removal, bleeding control, and lesion treatment with reduced patient trauma and faster recovery times.In 2024, global Endoscopic diagnostic and therapeutic devices production reached approximately 550 m units, with an average global market price of around US$ 13.22 perunit.

Population aging and rising GI/respiratory disease burdens, together with government-backed early screening and minimally invasive care, are shifting endoscopy from “diagnostics only” to “diagnostics-to-therapy.” Company annual reports and broker coverage indicate HD/NBI imaging, single-use scopes/consumables, and integrated energy platforms are lifting procedure throughput and bed turnover. Reimbursement expansion and volume-based procurement are catalyzing structural growth and penetration into lower-tier hospitals. Meanwhile, AI quality control and CADx/CADe improve early-cancer detection, and hospitals—via discipline building and day-surgery expansion—treat endoscopic therapy as a high-throughput, cost-effective growth engine.

Tighter regulation, higher standards, and rising compliance costs persist. Although localization of key components (sensors, optics, power/energy control) is progressing, consistency and clinical-evidence depth still require time. Single-use adoption heightens cost sensitivity; without aligned reimbursement and pricing mechanisms, margins can be compressed. Global supply chains face raw-material and logistics volatility, while overseas market access, registration timelines, and academic promotion needs elevate launch uncertainty and lengthen cash cycles.

Clinical demand is moving from “see” to “see clearly, treat effectively, and streamline.” Hospitals prefer end-to-end solutions—imaging, access, energy, and traceable SPD services—with day-surgery pathways driving share gains for single-use and easy-reprocessing products. Advanced procedures (ESD/POEM/ERCP/EMR/bronchial interventions) are scaling, pulling through high-end energy systems and interventional disposables; primary care favors durable, easy-to-maintain devices and standardized kits. Internationally, “premium + localized service” coexists with value-oriented demand in emerging markets, shaping multi-tier, scenario-based procurement logic.

This report presents a comprehensive overview of the global Endoscopic Diagnostic and Therapeutic Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Biopsy
• Hemostasis and Closure
• Dilation
• EUS
• EMR/ESD
• ERCP

Segment by Application

• Gastroenterology
• Respiratory
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Endoscopic Diagnostic and Therapeutic Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Gastroenterology, Respiratory, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact